MoonLake Immunotherapeutics screens first patient in Phase 2 study of the Nanobody® sonelokimab in…
MoonLake Immunotherapeutics screens first patient in Phase 2 study of the Nanobody® sonelokimab in active psoriatic arthritis…
GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.